08-11-2009, 04:59 PM
|
#314
|
UNDER CONDITIONAL MITIGATION
Join Date: Mar 2004
Location: Austin, TX
Posts: 20,012
|
From HuffPo:
Autism Rate Now at 1% of All US Children?
Quote:
According to data from the 2007 telephone survey of parents of nearly 82,000 US children, the odds of a child receiving an ASD diagnosis are one in 63. If it is a boy, the chances climb to a science fiction-like level of one in 38, or 2.6% of all male children in America.
|
Quote:
If there is an environmental component to autism, hopefully scientists will want to know which exposures might have increased between, say, 1992 and 1996.
One possible answer is the Hepatitis B vaccine, (which also contained 25 micrograms of mercury containing thimerosal).
Introduced in 1991, it was the first vaccine ever given on a population basis to newborn babies (within the first three hours after delivery) in human history.
But according to the CDC's National Immunization Survey (which also includes parental telephone interviews), only 8% of infant children received the Hep B vaccine in 1992, when that birth cohort showed an ASD rate of 60-per-10,000.
By 1994, the number of children receiving Hep B vaccine had reached just 27% -- and the cohort showed an ASD rate of 66-per-10,000.
By 1996, the Hep B coverage rate had risen to 82%, when that cohort's ASD rate exploded to around 100-per-10,000.
Correlation, obviously, does not equal causation. And no one is suggesting that Hepatitis B vaccine is the singular "cause" of autism. But the uptake rate of that particular immunization is at least one environmental factor that did demonstrably change during the period in question.
|
Quote:
A study published last October in the journal Neurology found that children who received the Hepatitis B vaccine series were 50% more likely to develop "central nervous system inflammatory demyelination" than children who did not receive the vaccine.
Most of this increase was due to the Engerix B brand of the vaccine, manufactured by the UK's GlaxoSmithKline. That brand increased the risk of demyelination by 74%, and patients with confirmed multiple sclerosis were nearly three times more likely to develop the disorder.
|
|
|
|